Purchase Order HHSN271201500018A

This is a sole-source firm-fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Prevention Genetics LLC, a for-profit limited liability company, to provide specialized genetic testing services. The contract, valued at $60,000.00, is for the continuation of genetic analysis of the TNXB and CAH-X genes to support the NIH's ongoing Natural History Study of Patients with Excess Androgens, protocol #06-CH-0011. Prevention Genetics is the only CLIA-certified...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded Greenwood Genetic Center Inc., doing business as Self Research Institute, a $50,000 firm fixed price purchase order for Clinical Genetic Testing for Undiagnosed Disease Program. Under the contract, Self Research Institute will provide clinical genetic testing services to support the National Institutes of Health's Clinical Genetic Testing for Undiagnosed Disease Program....

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed-price purchase order valued at $11,125 to Genedx, LLC of Montgomery Village, Maryland. This purchase card order is associated with Genedx's existing indefinite-delivery/indefinite-quantity contract with NIH Clinical Center to provide genetic testing services and will be used for monthly invoice payments from September 25, 2023 through September 25, 2023. Genedx, LLC is a wholly owned...

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...

This federal contract award, with ID HHSN269201700325PC, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The contract is for $95,385.00 and is for medical laboratory testing services, specifically supporting genetic testing and analysis. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market for this award. Genedx, as a wholly owned subsidiary of...

This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer at the National Institutes of Health (NIH) to Genedx, LLC, a for-profit limited liability company, for medical laboratory testing services. The contract award, valued at $97,833.65, has a performance period from January 14, 2016, to an ultimate completion date of the same day. Genedx, a wholly owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic...

This firm fixed-price contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Genedx, LLC, a provider of genetic testing and diagnostic services. The $5,250 contract tasks Genedx with providing a range of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing, in support of NIH's clinical research missions. This contract is not set aside for any socioeconomic...

This federal contract award is for medical laboratory testing services provided by Genedx, LLC to the National Institutes of Health (NIH) Clinical Center. The contract, valued at $100,000.00, is a firm fixed-price purchase order with an ultimate completion date of August 12, 2015. Genedx, a for-profit limited liability company, has been a provider of genetic testing services to the NIH, supporting various research and clinical programs, particularly at the NIH Clinical Center and the National...

This federal contract award, with an ID of 75N90018K00052, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The $82,281.25 firm fixed-price purchase order is for medical laboratory testing services, primarily to support research and clinical programs at the NIH. Genedx, a wholly-owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic services to the federal government. This...

This federal contract award is for medical laboratory testing services and was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a leading provider of genetic testing and diagnostic services. The contract, valued at $81,410.00, is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market. Genedx operates from its facilities in Maryland and has held several Indefinite Delivery Vehicle (IDV) contracts with the...